SCHEMBL7329667

SCHEMBL7329667

CC(C)(N)CNC(=O)COc1ccc(C2=NNC(=O)CC2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.55
LMNA P02545 3/20 0.55
NPY1R P25929 1/20 0.55
NPY2R P49146 1/20 0.55
KMT2A Q03164 1/20 0.52
HRH3 Q9Y5N1 4/20 0.47
PDE3B Q13370 8/20 0.44
PDE3A Q14432 7/20 0.44
SMN1; SMN2 Q16637 2/20 0.41
PDE4A P27815 2/20 0.40
PDE4B Q07343 2/20 0.40
PDE4C Q08493 2/20 0.40
PDE4D Q08499 2/20 0.40
KCNH2 Q12809 1/20 0.40
NPC1 O15118 2/20 0.39
RAB9A P51151 1/20 0.39
CASP3 P42574 1/20 0.39
SENP8 Q96LD8 1/20 0.39
SENP7 Q9BQF6 1/20 0.39
SENP6 Q9GZR1 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7333903 0.89 LMNA (0.60) MAPTLMNANPY1RNPY2RKMT2A
SCHEMBL7336275 0.85 PDE3B (0.47) MAPTLMNANPY1RNPY2RKMT2A
SCHEMBL7362081 0.84 MAPT (0.51) MAPTLMNANPY1RNPY2RKMT2A
SCHEMBL10474306 0.84 MAPT (0.65) MAPTLMNANPY1RNPY2RKMT2A
SCHEMBL7326890 0.84 MAPT (0.55) MAPTLMNANPY1RNPY2RKMT2A
SCHEMBL7326514 0.81 HRH3 (0.52) MAPTHRH3PDE3BPDE3ASMN1; SMN2
SCHEMBL7328015 0.81 HRH3 (0.52) MAPTHRH3PDE3BPDE3ASMN1; SMN2
SCHEMBL7328115 0.81 HRH3 (0.52) MAPTHRH3PDE3BPDE3ASMN1; SMN2
SCHEMBL7333910 0.80 MAPT (0.48) MAPTLMNANPY1RNPY2RKMT2A
SCHEMBL9630235 0.79 MAPT (0.67) MAPTLMNANPY1RNPY2RKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5204463-A Substituted methoxyphenyl-4,5 dihydro-3(2H)-pridazinones having cardiotonic and beta blocking activities GLAXO INC. (US) 1993-04-20 US disclosed
US-5096904-A Congestive heart failure GLAXO INC. (US) 1992-03-17 US disclosed
US-5053338-A Hydrolysis of ester to obtain an optically enriched mixture of a phenol enantiomer GLAXO INC. (US) 1991-10-01 US disclosed
EP-0412814-A2 Pyridazinones having cardiotonic and beta blocking activity GLAXO WELLCOME INC. (US) 1991-02-13 EP disclosed